Europe Immunochemistry Market to 2027- Regional Analysis and Forecasts by Application (Diagnostics, Drug Testing); Product (Antibodies, Equipment, Reagents, Kits); End User (Hospitals and Diagnostic Laboratories, Research Institutes, Others), and Country
The Europe immunochemistry market is expected to reach US$ 775.97 Mn in 2027 from US$ 430.82 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.
The growth of the market is driven by the factors such as, significantly increasing prevalence of cardiovascular diseases and rising incidence of diabetes. However, the market is likely to slower down its growth due to the shortage of skilled professionals.
The healthcare industry has been observing rapid transformations during the previous years. Various technological improvements have been witnessed in the segments such as, diagnosis and treatment options for chronic diseases. The increase in incidences of chronic illnesses, ageing population, are the primary factors fuelling the growth of healthcare segment.
Germany has a history of manufacturing high diagnostic imaging technologies, precision medical instruments and others. There has been an increase in the healthcare expenditure in the European countries during the previous years. As per Eurostat in 2016, healthcare expenditure in Germany was EUR 352 billion. Medical technologies is the priority of Healthcare/Life Sciences (HCT) industry. Whereas the healthcare expenditure of France was recorded as the second highest which was around EUR 257 billion, followed by the United Kingdom EUR 234 billion.
The above mentioned factors are expected to offer broad growth opportunities in the healthcare industry and this is expected to cause the demand for immunochemistry assays in the market.
Germany is expected to lead the market in the Europe region owing to the factors such as an increase in the number of cancer cases, the higher prevalence of the diseases, government initiatives, and investments for the research and development by the government bodies and private entities. Along with the government, private companies are also focusing on the development of the conditions in the country. Therefore, considering the above-mentioned factors the growth of the market in the country is likely to contribute the largest share in the Europe region during the forecast period.
Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Get more information on this report :
EUROPE IMMUNOHISTOCHEMISTRY – MARKET SEGMENTATION
By Product
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Equipment
- Slide Staining Systems
- Tissue Microarray Systems
- Slide Scanners
- Other Equipment
- Reagents
- Histological Stains
- Blocking and Fixation Reagents
- Chromogenic Substrates
- Stabilizers
- Solvents
- Proteolytic Enzymes
- Kits
By Application
- Diagnostics
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Drug Testing
By End User
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Others
By Geography
- Europe
- UK
- Germany
- France
- Spain
- Italy
Company Profiles
- PerkinElmer, Inc.
- Abcam Plc
- Agilent Technologies,
- Bio SB
- Bio-Rad Laboratories, Inc.
- Cell Signalling Technology, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher
- Merck KGaA
- Thermo Fisher Scientific, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. Europe Immunochemistry Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Immunochemistry Market – Market Landscape
4.1 Overview
4.2 Market Segmentation
4.2.1 Europe Immunochemistry Market – By Product
4.2.2 Europe Immunochemistry Market – By Application
4.2.3 Europe Immunochemistry Market – By End User
4.2.4 Europe Immunochemistry Market – By Country
4.3 PEST Analysis
5. Europe Immunochemistry Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Significantly Increasing Prevalence of Cardiovascular Diseases
5.1.2 Rising Incidence of Diabetes
5.2 Key Market Restraints
5.2.1 Shortage of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Rising Healthcare Expenditure in Europe
5.4 Future Trends
5.4.1 Rising Future Conferences and Workshops
5.5 Impact Analysis
6. Immunochemistry Market – Europe Analysis
6.1 Europe Immunochemistry Market Revenue Forecasts And Analysis
6.2 Performance of Key Players
7. Europe Immunochemistry Market Analysis – By Application
7.1 Overview
7.2 Europe Immunochemistry Market, By Application, 2018 & 2027 (%)
7.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
7.3.1.1 Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.4 Diagnostics
7.4.1 Overview
7.4.2 Europe Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Cancer
7.4.3.1 Overview
7.4.3.2 Europe Cancer Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Infectious Diseases
7.4.4.1 Overview
7.4.4.2 Europe Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5 Autoimmune Diseases
7.4.5.1 Overview
7.4.5.2 Europe Autoimmune Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.4.6 Nephrological Diseases
7.4.6.1 Overview
7.4.6.2 Europe Nephrological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Drug Testing
7.5.1 Overview
7.5.2 Europe Drug Testing Market Revenue and Forecast to 2027 (US$ Mn)
8. Europe Immunochemistry Market Analysis – By Product
8.1 Overview
8.2 Europe Immunochemistry Market, By Product, 2018 & 2027 (%)
8.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.1 Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.3 Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 Antibodies Market
8.4.1 Overview
8.4.2 Europe Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.3 Primary Antibodies
8.4.3.1 Overview
8.4.3.2 Europe Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4 Secondary Antibodies
8.4.4.1 Overview
8.4.4.2 Europe Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Equipment
8.5.1 Overview
8.5.2 Europe Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.3 Slide Staining Systems
8.5.3.1 Overview
8.5.3.2 Europe Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.4 Tissue Microarrays
8.5.4.1 Overview
8.5.4.2 Europe Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.5 Slide Scanners
8.5.5.1 Overview
8.5.5.2 Europe Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.6 Other Equipment
8.5.6.1 Overview
8.5.6.2 Europe Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Reagents
8.6.1 Overview
8.6.2 Europe Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.3 Histological Stains
8.6.3.1 Overview
8.6.3.2 Europe Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.4 Blocking & Fixation Reagents
8.6.4.1 Overview
8.6.4.2 Europe Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.5 Chromogenic Substrates
8.6.5.1 Overview
8.6.5.2 Europe Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.6 Stabilizers
8.6.6.1 Overview
8.6.6.2 Europe Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.7 Proteolytic Enzymes
8.6.7.1 Overview
8.6.7.2 Europe Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.8 Solvents
8.6.8.1 Overview
8.6.8.2 Europe Solvents Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Kits
8.7.1 Overview
8.7.2 Europe Kits Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Immunochemistry Market Analysis – By End User
9.1 Overview
9.2 Europe Immunochemistry Market, By End User, 2018 & 2027 (%)
9.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Hospital & Diagnostic Laboratories
9.4.1 Overview
9.4.2 Europe Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Research Institutes
9.5.1 Overview
9.5.2 Europe Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others End Users
9.6.1 Overview
9.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Europe Immunochemistry Market Revenue and Forecasts To 2027
10.1 Overview
10.1.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.2 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.2.1 Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.3.1 Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.2 Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.3 Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.4 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.5 Europe Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)
10.1.6 UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.1 UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.2 UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.6.2.1 UK Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3 UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.6.3.1 UK Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3.2 UK Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3.3 UK Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.4 UK Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.7 Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.2 Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.7.2.1 Germany Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3 Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.7.3.1 Germany Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3.2 Germany Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3.3 Germany Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.4 Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.8 France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 France Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.8.2.1 France Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3 France Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.8.3.1 France Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3.2 France Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3.3 France Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.4 France Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.9 Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.2 Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.9.2.1 Italy Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.3 Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.9.3.1 Italy Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.3.2 Italy Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.3.3 Italy Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.4 Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.10 Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.2 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.10.2.1 Spain Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.3 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.10.3.1 Spain Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.3.2 Spain Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.3.3 Spain Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.4 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. Immunochemistry Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies done by the companies in the Market, 2018 (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic developments
11.4.1 Overview
12. Immunohistochemistry Market–Key Company Profiles
12.1 Bio SB
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product portfolio
12.1.5 SWOT ANALYSIS
12.1.6 Key Developments
12.2 Cell Signaling Technology, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product portfolio
12.2.5 SWOT ANALYSIS
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Merck KGaA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PerkinElmer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Abcam Plc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Agilent Technologies, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Information
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Danaher
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Information
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary Of Terms
LIST OF TABLES
Table 1. Prevalence Of Diabetes In The Region, 2017
Table 2. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 3. Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 4. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 5. Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 6. Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 7. Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 8. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 9. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 10. Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 11. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 12. Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 13. Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 14. Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 15. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 16. UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 17. UK Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 18. UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 19. UK Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 20. UK Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 21. UK Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 22. UK Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 23. Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 24. Germany Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 25. Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 26. Germany Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 27. Germany Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 28. Germany Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 29. Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 30. France Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 31. France Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 32. France Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 33. France Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 34. France Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 35. France Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 36. France Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 37. Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 38. Italy Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 39. Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 40. Italy Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 41. Italy Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 42. Italy Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 43. Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 44. Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 45. Spain Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 46. Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 47. Spain Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 48. Spain Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 49. Spain Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 50. Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 1. Organic Developments Done By Companies
Table 2. Inorganic developments done by Companies
Table 3. Glossary Of Terms, Immunochemistry Market
LIST OF FIGURES
Figure 1. Europe Immunochemistry Market Overview
Figure 2. Germany is Expected To Show Remarkable Growth During The Forecast Period
Figure 3. Europe Immunochemistry Market- Leading Country Markets (US$ Mn)
Figure 4. Immunochemistry Market Segmentation
Figure 5. Europe PEST Analysis
Figure 6. Immunochemistry Market Impact Analysis of Drivers & Restraints
Figure 7. Europe Immunochemistry Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 8. Prominent Players in the Immunohistochemistry Market
Figure 9. Europe Immunochemistry Market, By Application, 2018 & 2027 (%)
Figure 10. Europe Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 11. Europe Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. Europe Infectious Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. Europe Autoimmune Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. Europe Nephrological Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. Europe Drug Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. Europe Immunochemistry Market, By Product 2018 & 2027 (%)
Figure 17. Europe Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Europe Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Europe Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Europe Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Europe Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Europe Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Europe Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Europe Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Europe Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Europe Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Europe Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Europe Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Europe Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Europe Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Europe Solvents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. Europe Kits Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Europe Immunochemistry Market, By End User, 2018 & 2027 (%)
Figure 34. Europe Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Europe Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Europe Immunohistochemistry Market Revenue Overview, by Country (2018) (US$ Mn)
Figure 38. Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Europe Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)
Figure 40. UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. Growth Strategies done by the companies in the Market, 2018 (%)
The List of Companies - Europe Immunochemistry Market
- PerkinElmer, Inc.
- Abcam Plc
- Agilent Technologies,
- Bio SB
- Bio-Rad Laboratories, Inc.
- Cell Signalling Technology, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe immunochemistry market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe immunochemistry market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.